Effects of chronic treatment with the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in rats.

Original article


Sherif F, Oreland L.

Department of Pharmacology, University for Medical Sciences, Tripoli, Libya.

Behav Brain Res. 1994 Jul 29;63(1):11-5.


Vigabatrin (gamma-vinyl GABA, GVG) is an irreversible inhibitor of the enzyme GABA-transaminase (GABA-T) GABA-T is the enzyme responsible for the catabolism of the major inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the mammalian brain. Previously, a single administration of vigabatrin at a dose of 50 mg/kg was found to produce an anxiolytic-like effect on exploratory behaviour in rats and a decrease in the locomotor activity, 2 and 4 h after the injection and, presently, 24 h after the injection. Using an elevated plus-maze and open field tests, we investigated whether or not chronic administration of vigabatrin at the same dose (50 mg/kg/day, i.p.) for 14 and 28 days induces tolerance with regard to these effects. The anxiolytic-like effect of vigabatrin was found to persist in the elevated plus-maze test, as was the case with diazepam (5 mg/kg/day, i.p.), 24 h after the last injection. However, in the plus-maze and open field tests, the effects of vigabatrin and diazepam on the general locomotor activity were not found to be decreased.

Keywords: Gamma-vinyl GABA; Vigabatrin; GABA-transaminase; Elevated plus-maze test; Open field test; Repeated treatment; Anxiety; Exploratory behavior

Link/DOI: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6SYP-485YPF9-1K&_user=10&_coverDate=07%2F29%2F1994&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=d2030be424540d18c56fbc42ecba1e87